Prior CABG (HR 2.12) and multivessel disease (HR 2.89) were the strongest predictors of 1-year rehospitalization for ACS and revascularization, respectively, following acute myocardial infarction.
Cohort (n=3,283)
Sí
Specific clinical factors, such as prior CABG, female sex, and multivessel disease, rather than the GRACE mortality score, predict 1-year rehospitalization for ACS and unplanned revascularization after AMI.
Estimación del efecto: HR 2.12 (95% CI 1.45-3.10)
BACKGROUND: Rehospitalizations for acute coronary syndromes (ACS) and coronary revascularization after an acute myocardial infarction (AMI) are not only common and costly but can also impact patients' quality of life. In contrast to mortality and all-cause readmissions, little insight is available into risk factors associated with ACS and revascularization after AMI. METHODS AND RESULTS: In a multicenter AMI registry, we examined the rates and predictors of rehospitalizations for ACS and revascularization within the year after AMI among 3283 patients. Staged revascularization procedures were excluded. Kaplan-Meier estimated rates of rehospitalization due to ACS and revascularization were 6.8% and 4.1%, respectively. In hierarchical, multivariable models, the strongest predictors of rehospitalization for ACS were coronary artery bypass graft prior to AMI hospitalization (hazard ratio HR 2.12, 95% CI 1.45 to 3.10), female sex (HR 1.67, 95% CI 1.23 to 2.25), and in-hospital PCI (HR 1.85, 95% CI 1.28 to 2.69). The strongest predictors of subsequent revascularization were multivessel disease (HR 2.89, 95% CI 1.90 to 4.39) and in-hospital percutaneous coronary intervention with a bare metal stent (HR 2.08, 95% CI 1.19 to 3.63). The Global Registry of Acute Coronary Events mortality risk score was not associated with the risk of rehospitalization for ACS or revascularization. CONCLUSIONS: Unique characteristics are associated with admissions for ACS and revascularization, as compared with survival. These multivariable risk predictors may help identify patients at high risk for ACS and revascularization, in whom intensification of secondary prevention therapies or closer post-AMI follow-up may be warranted.
Arnold et al. (Fri,) conducted a cohort in Acute Myocardial Infarction (n=3,283). Risk factor assessment was evaluated on Rehospitalization for ACS (HR 2.12, 95% CI 1.45-3.10). Prior CABG (HR 2.12) and multivessel disease (HR 2.89) were the strongest predictors of 1-year rehospitalization for ACS and revascularization, respectively, following acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: